U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Monday.
Shares of BioAge Labs, Inc. BIOA fell sharply in today’s pre-market trading after the company announced discontinuation of STRIDES Phase 2 clinical trial evaluating Azelaprag in combination with Tirzepatide for the treatment of obesity.
BioAge Labs shares tumbled 68.6% to $6.30 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Palmer Square Capital BDC Inc PSBD shares tumbled 18.3% to $13.00 in pre-market trading.
- Bicara Therapeutics Inc BCAX fell 14.7% to $18.00 in pre-market trading after gaining 8% on Friday.
- ZJK Industrial Co Ltd ZJK fell 10.9% to $12.55 in pre-market trading.
- Heritage Commerce Corp. HTBK declined 9.7% to $9.50 in pre-market trading.
- Bel Fuse Inc BELFB declined 7.1% to $78.00 in pre-market trading.
- Riot Platforms Inc RIOT fell 6.7% to $12.08 in pre-market trading. Riot Platforms announced a proposed private offering of $500 million of convertible senior notes.
- ZimVie Inc ZIMV fell 6.5% to $13.03 in pre-market trading.
- AppLovin Corporation APP declined 5.8% to $378.00 in pre-market trading after gaining around 6% on Friday.
Now Read This:
Overview Rating:
Speculative
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.